Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma

✍ Scribed by Kosaku Uchida; Masashi Kondo; Shin Takeda; Hirotaka Osada; Toshitada Takahashi; Akimasa Nakao; Takashi Takahashi

• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 158 KB
• Volume: 18
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/(sici)1098-2744(199704)18:4<193::aid-mc2>3.0.co;2-f

✦ Synopsis

The insulin-like growth factor 2 (IGF2) gene is regulated in a complex manner, involving developmentally regulated use of four different promoters as well as transcriptional repression of the maternal allele due to genomic imprinting. It has been well documented that liver is an exceptional organ in which overall transcription from the four IGF2 promoters is markedly imbalanced towards preferential paternal expression only in fetal life, this being relaxed during the postnatal period, resulting in biallelic expression thereafter. We previously reported a marked allelic-expression imbalance in the overall transcription of IGF2 in hepatocellular carcinoma (HCC), leading to preferential expression nonrandomly from the paternal allele. The study presented here, using 18 HCC specimens taken directly from patients, showed that this molecular change often reflects promoters switching from the adult P1 promoter to the fetal P2, P3, and P4 promoters. Interestingly, however, we found that restoration of allele-specific expression of the P1 promoter nonrandomly from the paternal allele was also frequent in HCC suggesting retention of an imprint for paternal expression from the P1 promoter of IGF2 in adult normal liver and altered availability of its modifying factor or factors in HCC. Further studies of the molecular mechanisms involved in the fluctuation of promoter usage and genomic imprinting of IGF2 are warranted to gain an insight into the biology of the liver in terms of development and oncogenesis.